Mice treated with anti-PD1 or terbinafine alone exhibited a moderate antitumor response, whereas the combinatory group showed significantly enhanced tumor regression, accompanied by a remarkable increase in tumor-infiltrating CD8+ T cells (, figure 6B–D). Here, PDCD1 is linked to neoplasm.